ConductScience.org, home

Paper3000292

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Wolfson JS and 1 other. Antimicrob Agents Chemother, 1985. Cited by 666 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Papers, record 3000292. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000292

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
666
iCite
Relative citation ratio, by iCite
28.3
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wolfson JSJ S
2Hooper DCD C

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
QuinolinesMajor topic
Chemical Phenomena
Chemistry
Drug Resistance, Microbial
Structure-Activity Relationship
Topoisomerase II Inhibitors

Source PubMed

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,236,748In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6236748PubMed
26,586,712In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.J Antimicrob Chemother1984https://conductscience.org/library/papers/6586712PubMed
36,234,858Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6234858PubMed
46,203,890Investigations into the mechanism of action of the antibacterial agent norfloxacin.J Antimicrob Chemother1984https://conductscience.org/library/papers/6203890PubMed
56,098,219Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6098219PubMed
66,721,464In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6721464PubMed
76,383,207Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6383207PubMed
84,895,844Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.J Bacteriol1969https://conductscience.org/library/papers/4895844PubMed
93,970,478The quinolones.Ann Intern Med1985https://conductscience.org/library/papers/3970478PubMed
106,222,695In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6222695PubMed
1116,559,090Nalidixic Acid and the Metabolism of Escherichia coli.J Bacteriol1970https://conductscience.org/library/papers/16559090PubMed
126,232,895Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6232895PubMed
136,271,730New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.J Bacteriol1981https://conductscience.org/library/papers/6271730PubMed
146,097,803Biology of bacterial deoxyribonucleic acid topoisomerases.Microbiol Rev1984https://conductscience.org/library/papers/6097803PubMed
157,452,690Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.J Med Chem1980https://conductscience.org/library/papers/7452690PubMed
166,227,484In vitro activity of norfloxacin against Mycoplasma hominis and Ureaplasma urealyticum.Eur J Clin Microbiol1983https://conductscience.org/library/papers/6227484PubMed
176,240,224In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6240224PubMed
186,422,043
Pyridonecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent.
J Med Chem1984https://conductscience.org/library/papers/6422043PubMed
193,156,026Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.Chemotherapy1985https://conductscience.org/library/papers/3156026PubMed
206,227,281Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6227281PubMed

See all 76 references

Cited by226

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 666 citations.

PMIDTitleJournalYearIn PapersSource
42,038,474
Comparative in vitro antibacterial activity of herbal extracts from Piper betle L., Bauhinia scandens L. and Chromolaena odorata against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
PeerJ2026https://conductscience.org/library/papers/42038474PubMed
41,991,528Beyond metabolic dormancy: metabolic rewiring in bacterial persistence.Nat Commun2026https://conductscience.org/library/papers/41991528PubMed
41,465,289Experimental Study and Molecular Modeling of Antibody Interactions with Different Fluoroquinolones.Int J Mol Sci2025https://conductscience.org/library/papers/41465289PubMed
41,253,746Therapeutic targeting of endothelial calcium signaling accelerates the resolution of lung injury.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41253746PubMed
40,430,428Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40430428PubMed
40,317,056Antibiotic type and dose variably affect microbiomes of a disease-resistant Acropora cervicornis genotype.Environ Microbiome2025https://conductscience.org/library/papers/40317056PubMed
39,126,607Green Approach for Simultaneous Quantitative Analysis of Fluoroquinolones in the Environment using Three-Dimensional Fluorescence Coupled with Second-Order Calibration Method.J Fluoresc2025https://conductscience.org/library/papers/39126607PubMed
38,045,542Contribution of the SOS response and the DNA repair systems to norfloxacin induced mutations in E. coli.Mar Life Sci Technol2023https://conductscience.org/library/papers/38045542PubMed
37,891,886Boswellia Essential Oil: Natural Antioxidant as an Effective Antimicrobial and Anti-Inflammatory Agent.Antioxidants (Basel)2023https://conductscience.org/library/papers/37891886PubMed
37,754,560Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus.Microbiol Spectr2023https://conductscience.org/library/papers/37754560PubMed
37,630,269Fluoroquinolone Analogs, SAR Analysis, and the Antimicrobial Evaluation of 7-Benzimidazol-1-yl-fluoroquinolone in In Vitro, In Silico, and In Vivo Models.Molecules2023https://conductscience.org/library/papers/37630269PubMed
37,247,149Metabolic variation and oxidative stress response of blue mussels (Mytilus sp.) perturbed by norfloxacin exposure.Environ Sci Pollut Res Int2023https://conductscience.org/library/papers/37247149PubMed
36,624,327Enrofloxacin Poisoning: A Rare Occurrence in Children.Indian J Pediatr2023https://conductscience.org/library/papers/36624327PubMed
36,466,935Metal-Organic Framework-Based Composites for the Detection and Monitoring of Pharmaceutical Compounds in Biological and Environmental Matrices.Water Air Soil Pollut2022https://conductscience.org/library/papers/36466935PubMed
36,119,794Alhagi maurorum aqueous extract protects against norfloxacin-induced hepato-nephrotoxicity in rats.Chin Herb Med2020https://conductscience.org/library/papers/36119794PubMed
35,409,007Enrofloxacin-The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?Int J Mol Sci2022https://conductscience.org/library/papers/35409007PubMed
35,283,843Interactions Between Intestinal Microbiota and Neural Mitochondria: A New Perspective on Communicating Pathway From Gut to Brain.Front Microbiol2022https://conductscience.org/library/papers/35283843PubMed
34,908,449Enoxacin Shows Broad-Spectrum Antiviral Activity against Diverse Viruses by Enhancing Antiviral RNA Interference in Insects.J Virol2022https://conductscience.org/library/papers/34908449PubMed
34,703,723pH-driven enhancement of anti-tubercular drug loading on iron oxide nanoparticles for drug delivery in macrophages.Beilstein J Nanotechnol2021https://conductscience.org/library/papers/34703723PubMed
33,652,626Characterization of a Novel Variant of the Quinolone-Resistance Gene qnrB (qnrB89) Carried by a Multi-Drug Resistant Citrobacter gillenii Strain Isolated from Farmed Salmon in Chile.Antibiotics (Basel)2021https://conductscience.org/library/papers/33652626PubMed

See all 226 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3000292

GET https://conductscience.org/api/papers/v1/3000292/references?page=2